Novo Nordisk
NVO
NVO
1,145 hedge funds and large institutions have $22.1B invested in Novo Nordisk in 2023 Q1 according to their latest regulatory filings, with 175 funds opening new positions, 327 increasing their positions, 428 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 1,047 → 1,145 (+98)
0.07% less ownership
Funds ownership: 16.45% → 16.38% (-0.07%)
24% less repeat investments, than reductions
Existing positions increased: 327 | Existing positions reduced: 428
Holders
1,145
Holding in Top 10
56
Calls
$296M
Puts
$228M
Top Buyers
| 1 | +$504M | |
| 2 | +$502M | |
| 3 | +$126M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$115M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$66.2M |
Top Sellers
| 1 | -$360M | |
| 2 | -$256M | |
| 3 | -$216M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$163M |
| 5 |
Morgan Stanley
New York
|
-$86.5M |